Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis
- PMID: 26131012
- PMCID: PMC4475772
Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis
Abstract
Background: Polycystic ovarian syndrome (PCOS) is a common endocrinopathy that accompanied with long term complications. The early diagnosis of this syndrome can prevent it.
Objective: The aim was to determine the role of anti-mullerian hormon (AMH) in PCOS diagnosis and to find cut off level of it.
Materials and methods: In this cross sectional study, 117 women between 20-40 years old were participated in two groups: 60 PCOS women (based on Rotterdam criteria consensus) as the case group and 57 normal ovulatory women as the control group. In day 2-4 of cycle, transvaginal sonography was performed and serum hormonal level of AMH, luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2), testosterone, fasting blood sugar (FBS), thyroid stimulating hormone (TSH), and prolactin (PRL) were measured in all of participants. For all of them score of hirsutism (base on Freeman-Galloway scoring) was determined.
Results: There were statistically significant in irregular pattern of menstruation, AMH and FSH level, and presence of hirsutism between two groups. But regarding mean of age, body mass index, plasma level of PRL, TSH, LH, Testosterone, FBS, and E2 differences were not significant. Construction by ROC curve present 3.15 ng/ml as AMH cut off with 70.37% sensitivity and 77.36% specificity in order to PCOS diagnosis.
Conclusion: AMH with cut off level of 3.15 ng/ml with sensitivity 70.37% and specificity 77.36% could use for early diagnosis of PCOS patients.
Keywords: Anti-mullerian hormon; Hirsutism; Polycystic ovarian syndrome; Rotterdam criteria.
Figures
Similar articles
-
Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women.Int J Womens Health. 2023 May 29;15:837-843. doi: 10.2147/IJWH.S403347. eCollection 2023. Int J Womens Health. 2023. PMID: 37275514 Free PMC article.
-
Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15. Acta Obstet Gynecol Scand. 2013. PMID: 23980726
-
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16. Hum Reprod. 2014. PMID: 24435776
-
Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.Hum Reprod Update. 2016 Nov;22(6):709-724. doi: 10.1093/humupd/dmw027. Epub 2016 Aug 27. Hum Reprod Update. 2016. PMID: 27566840 Review.
-
The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:82-7. doi: 10.1016/j.ejogrb.2016.01.029. Epub 2016 Feb 10. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26914398 Review.
Cited by
-
A Cross-Sectional Study on Potential Ovarian Volume and Related Factors in Women with Polycystic Ovary Syndrome from Infertile Couples.Int J Womens Health. 2021 Aug 29;13:793-801. doi: 10.2147/IJWH.S329082. eCollection 2021. Int J Womens Health. 2021. PMID: 34512036 Free PMC article.
-
Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions.Diagnostics (Basel). 2023 Oct 25;13(21):3301. doi: 10.3390/diagnostics13213301. Diagnostics (Basel). 2023. PMID: 37958197 Free PMC article.
-
Correlation of Serum Homocysteine Levels and Hyperinsulinaemia with Body Mass Index in Polycystic Ovarian Syndrome.J Hum Reprod Sci. 2022 Jan-Mar;15(1):34-41. doi: 10.4103/jhrs.jhrs_147_21. Epub 2022 Mar 31. J Hum Reprod Sci. 2022. PMID: 35494205 Free PMC article.
-
Structural Changes in the Medial Prefrontal Cortex and Anterior Cingulate Cortex of Dehydroepiandrosterone-Induced Wistar Rat Model of Polycystic Ovarian Syndrome.Basic Clin Neurosci. 2022 Sep-Oct;13(5):695-708. doi: 10.32598/bcn.2022.2985.1. Epub 2022 Sep 1. Basic Clin Neurosci. 2022. PMID: 37313023 Free PMC article.
-
PCOS Influences the Expression of AMHRII in the Endometrium of AEH During the Reproductive Age.Diagnostics (Basel). 2024 Dec 20;14(24):2872. doi: 10.3390/diagnostics14242872. Diagnostics (Basel). 2024. PMID: 39767233 Free PMC article.
References
-
- Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685–697. - PubMed
-
- Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab. 2006;91:4842–4848. - PubMed
-
- Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–4245. - PubMed
-
- Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77–83. - PubMed
-
- Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88:5957–5962. - PubMed
LinkOut - more resources
Full Text Sources